Medicenna Therapeutics Corp.

Biotechnology • Healthcare • Toronto, ON, United States • MDNAF (OQX)

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a tumor-targeting and activatable masked anti-PD-1-IL-2 BiSKITTM for cancer; and MDNA132, an IL-13 Superkine for various tumors. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Insider Buying: Medicenna Therapeutics (TSE:MDNA) Insider Acquires 10,000 Shares of Stock - MarketBeat

MarketBeat • Dec 15

The Truth About Medicenna Therapeutics (MDNA): Tiny Cancer Stock With Massive Hype – Smart Bet or - AD HOC NEWS

AD HOC NEWS • Jan 2

Medicenna Therapeutics Announces Participation in Upcoming Conferences - GlobeNewswire

GlobeNewswire • Oct 20

Why Medicenna Therapeutics Corp Shares Are Rising - TipRanks

TipRanks • Dec 10

3 TSX Penny Stocks With Market Caps Under CA$90M - Yahoo Finance

Yahoo Finance • Oct 3

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Medicenna Therapeutics Corp. had layoffs?

No layoff events have been recorded for Medicenna Therapeutics Corp. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Medicenna Therapeutics Corp. have?

Medicenna Therapeutics Corp. has approximately 18 employees.

What industry is Medicenna Therapeutics Corp. in?

Medicenna Therapeutics Corp. operates in the Biotechnology industry, within the Healthcare sector.

Is Medicenna Therapeutics Corp. a publicly traded company?

Yes, Medicenna Therapeutics Corp. is publicly traded under the ticker symbol MDNAF on the OQX. The company has a market capitalization of approximately $0.06 billion.

Where is Medicenna Therapeutics Corp. headquartered?

Medicenna Therapeutics Corp. is headquartered in Toronto, ON, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.